Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ovid Therapeutics Inc. - Common Stock (NQ:OVID)

2.770 -0.030 (-1.07%)

Streaming Delayed Price Updated: 1:22 PM EDT, Sep 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	397,699
Open	2.750
Bid (Size)	2.760 (4,100)
Ask (Size)	2.770 (1,800)
Prev. Close	2.800
Today's Range	2.730 - 2.810
52wk Range	1.120 - 3.105
Shares Outstanding	70,417,345
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ovid Therapeutics to Participate in Upcoming Investor Conferences

September 03, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

August 13, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Performance

YTD	+57.4%	+57.4%
1 Month	+5.7%	+5.7%
3 Month	+17.4%	+17.4%
6 Month	+29.4%	+29.4%
1 Year	+123.4%	+123.4%

More News

Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

July 08, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics to Participate in Upcoming Investor Conferences

June 04, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

OVID Therapeutics Inc (NASDAQ:OVID) Passes Minervini's High-Growth Momentum and Trend Template Filters ↗

March 30, 2026

Via Chartmill

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

June 03, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

May 12, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Here's Why Ovid Therapeutics Stock Popped Higher Today ↗

March 18, 2026

Via The Motley Fool

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 18, 2026

Via Chartmill

Discover the top movers in Wednesday's pre-market session. ↗

March 18, 2026

Via Chartmill

Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results

March 18, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics Announces Pricing of $60 Million Private Placement

March 18, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics to Participate in Upcoming Investor Conferences

February 25, 2026

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)

December 18, 2025

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

December 02, 2025

From Ovid Therapeutics Inc.

Via GlobeNewswire

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

November 17, 2025

Via Benzinga

OVID THERAPEUTICS INC (NASDAQ:OVID) Announces Leadership Transition and Key Pipeline Milestones Following Q3 2025 Results ↗

November 12, 2025

Via Chartmill

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

November 12, 2025

From Ovid Therapeutics Inc.

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

October 03, 2025

Via Chartmill

Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why ↗

October 03, 2025

Via Stocktwits

These stocks that are showing activity before the opening bell on Friday. ↗

October 03, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 03, 2025

Via Benzinga

Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds

October 03, 2025

From Ovid Therapeutics Inc.

Via GlobeNewswire

Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile

October 03, 2025

From Ovid Therapeutics Inc.

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗

September 02, 2025

Via Chartmill

Frequently Asked Questions

Is Ovid Therapeutics Inc. - Common Stock publicly traded?

Yes, Ovid Therapeutics Inc. - Common Stock is publicly traded.

What exchange does Ovid Therapeutics Inc. - Common Stock trade on?

Ovid Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Ovid Therapeutics Inc. - Common Stock?

The ticker symbol for Ovid Therapeutics Inc. - Common Stock is OVID on the Nasdaq Stock Market

What is the current price of Ovid Therapeutics Inc. - Common Stock?

The current price of Ovid Therapeutics Inc. - Common Stock is 2.770

When was Ovid Therapeutics Inc. - Common Stock last traded?

The last trade of Ovid Therapeutics Inc. - Common Stock was at 09/08/26 01:22 PM ET

What is the market capitalization of Ovid Therapeutics Inc. - Common Stock?

The market capitalization of Ovid Therapeutics Inc. - Common Stock is 195.06M

How many shares of Ovid Therapeutics Inc. - Common Stock are outstanding?

Ovid Therapeutics Inc. - Common Stock has 195M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.